Breast Cancer Female

Oncology
2
Pipeline Programs
4
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

E
EisaiChina - Liaoning
1 program
1
Eribulin Injection [Halaven]Phase 41 trial
Active Trials
NCT05033769Unknown82Est. Sep 2023
Sanofi
SanofiPARIS, France
1 program
1
paclitaxelPhase 25 trials
Active Trials
NCT01447706Completed223Est. Jun 2015
NCT01209195Completed41Est. Jul 2014
NCT01204125Completed141Est. Feb 2017
+2 more trials
Alliance Pharmaceuticals
2 programs
HippotherapyN/A1 trial
State-Trait Anxiety InventoryN/A1 trial
Active Trials
NCT04350398Completed83Est. Aug 2022
NCT06008301Withdrawn0Est. Jun 2027
Varian Medical Systems
1 program
Prone and supine simulationN/A1 trial
Active Trials
NCT02237469UnknownEst. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
EisaiEribulin Injection [Halaven]
Sanofipaclitaxel
Sanofipaclitaxel
Sanofipaclitaxel
Sanofipaclitaxel
Sanofipaclitaxel
Alliance PharmaceuticalsState-Trait Anxiety Inventory
Alliance PharmaceuticalsHippotherapy
Varian Medical SystemsProne and supine simulation

Clinical Trials (9)

Total enrollment: 592 patients across 9 trials

NCT05033769EisaiEribulin Injection [Halaven]

Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer

Start: Mar 2021Est. completion: Sep 202382 patients
Phase 4Unknown
NCT01447706Sanofipaclitaxel

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Start: Oct 2011Est. completion: Jun 2015223 patients
Phase 2Completed
NCT01204125Sanofipaclitaxel

Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients

Start: Sep 2010Est. completion: Feb 2017141 patients
Phase 2Completed
NCT00687687Sanofipaclitaxel

Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

Start: May 2008Est. completion: Dec 201122 patients
Phase 2Completed
NCT00071188Sanofipaclitaxel

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Start: Feb 2004Est. completion: Oct 2007
Phase 2Completed
NCT01209195Sanofipaclitaxel

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Start: Oct 2010Est. completion: Jul 201441 patients
Phase 1Completed
NCT06008301Alliance PharmaceuticalsState-Trait Anxiety Inventory

Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)

Start: Apr 2025Est. completion: Jun 20270
N/AWithdrawn
NCT04350398Alliance PharmaceuticalsHippotherapy

Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer

Start: Apr 2017Est. completion: Aug 202283 patients
N/ACompleted
NCT02237469Varian Medical SystemsProne and supine simulation

Prone Breast Radiotherapy Treatment Planning Observational Study

Start: Sep 2010Est. completion: Dec 2023
N/AUnknown

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
9m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
9m ago

Office Administrator

SystImmune
9m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
20m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
23m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
23m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)